Investors may believe Sichuan Goldstone Asia Pharmaceutical ...

Investors may believe Sichuan Goldstone Asia Pharmaceutical Inc.'s strong earnings growth could underperform the market, causing its low P/E ratio. If recent earnings trends persist, a significant share price rise seems unlikely.